×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 6: What’s the Value to Patients and What Challenges Exist to Access?
Learning Objective : At the conclusion of this session, participants should be able to:- Describe the current environment in the United States related to patient access to biosimilars
- Identify challenges in patient access to biosimilars including regulatory issues, payment issues, and education
- Describe 1-2 ways that current challenges may be improved
Speaker(s)
![Benjamin Chandhok](/_Images/member/Generic_Image_Missing-Profile.jpg)
Implications to Biosimilar Access for Patients with Arthritis
Benjamin Chandhok
Arthritis Foundation, United States
Senior Director, State Legislative Affairs
![Laura Lasiter](/_Images/member/Generic_Image_Missing-Profile.jpg)
How Can Biosimilars Benefit Patients with Cancer and What Are Challenges to Access?
Laura Lasiter
Friends of Cancer Research, United States
Science Policy Analyst